Analysis of ESR1 Mutation Spectrum from Non-Small-Cell Lung Cancer in Chinese Patients

被引:0
|
作者
Xu, C. [1 ]
Wang, W. [2 ]
Zhang, Q. [3 ]
Zhuang, W. [4 ]
Zhu, Y. [5 ]
Huang, Y. [4 ]
Chen, Y. [3 ]
Chen, G. [3 ]
Fang, M. [2 ]
Lv, T. [6 ]
Song, Y. [6 ]
机构
[1] Fujian Canc Hosp, Fuzhou, Fujian, Peoples R China
[2] Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China
[3] Fujian Canc Hosp, Pathol, Fuzhou, Fujian, Peoples R China
[4] Fujian Canc Hosp, Med Oncol, Fuzhou, Fujian, Peoples R China
[5] Zhejiang Rongjun Hosp, Jiaxing, Peoples R China
[6] Jinling Hosp, Nanjing, Jiangsu, Peoples R China
关键词
Non-small-cell lung cancer; Prognosis; ESR1; mutation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.03-08
引用
收藏
页码:S913 / S913
页数:1
相关论文
共 50 条
  • [41] Influence of Chemotherapy on EGFR Mutation Status Among Patients With Non-Small-Cell Lung Cancer
    Bai, Hua
    Wang, Zhijie
    Chen, Keneng
    Zhao, Jun
    Lee, J. Jack
    Wang, Shuhang
    Zhou, Qinghua
    Zhuo, Minglei
    Mao, Li
    An, Tongtong
    Duan, Jianchun
    Yang, Lu
    Wu, Meina
    Liang, Zhen
    Wang, Yuyan
    Kang, Xiaozheng
    Wang, Jie
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (25) : 3077 - 3083
  • [42] Cardiovascular events in eGFR-mutation non-small-cell lung cancer patients on osimertinib
    Mensah, Samuel Akaakole
    Ahmad, Syed
    Alruwaili, Waleed
    Raval, Rutu
    Gonuguntla, Karthik
    Patel, Brijesh
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [43] The predictive value of uncommon EGFR mutation in patients with non-small-cell lung cancer.
    Tu, Haiyan
    Ke, Ee
    Sun, Yue-Li
    Zheng, Ming-Ying
    Yang, Jin-Ji
    Wang, Zhen
    Wu, Si-Pei
    Su, Jian
    Zhang, Xuchao
    Bai, Xiao-Yan
    Yang, Xue-Ning
    Zhong, Wenzhao
    Yan, Hong-Hong
    Zhou, Qing
    Wu, Yi-Long
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [44] Clinicopathological characteristics of&IT POLE&IT mutation in patients with non-small-cell lung cancer
    Song, Zhengbo
    Cheng, Guoping
    Xu, Chunwei
    Wang, Wenxian
    Shao, Yang
    Zhang, Yiping
    LUNG CANCER, 2018, 118 : 57 - 61
  • [45] The EGFR mutation and its correlation with response of gefitinib in previously treated Chinese patients with advanced non-small-cell lung cancer
    Zhang, XT
    Li, LY
    Mu, XL
    Cui, QC
    Chang, XY
    Song, W
    Wang, SL
    Wang, MZ
    Zhong, W
    Zhang, L
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1334 - 1342
  • [46] ctDNA Assessment of EGFR Mutation Status in Chinese Patients with Advanced Non-Small-Cell Lung Cancer in Read World Setting
    Zhang, S.
    Zhu, L.
    Chen, X.
    Chen, E.
    Li, Y.
    Fang, H.
    Feng, Y.
    Qiong, Z.
    He, H.
    Ma, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2212 - S2212
  • [47] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Yiming Zhao
    Junqi Yi
    Juanjuan Xiang
    Wei Jia
    Anqi Chen
    Liyu Chen
    Leliang Zheng
    Wen Zhou
    Minghua Wu
    Zheng Yu
    Jingqun Tang
    BMC Microbiology, 23
  • [48] Association Between Molecular Spectrum of EZH2 Variants and Prognosis in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
    Wang, H.
    Xu, C.
    Wang, W.
    Zhang, Q.
    Zhuang, W.
    Zhu, Y.
    Huang, Z.
    Chen, G.
    Fang, M.
    Lv, T.
    Song, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S954 - S955
  • [49] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Zhao, Yiming
    Yi, Junqi
    Xiang, Juanjuan
    Jia, Wei
    Chen, Anqi
    Chen, Liyu
    Zheng, Leliang
    Zhou, Wen
    Wu, Minghua
    Yu, Zheng
    Tang, Jingqun
    BMC MICROBIOLOGY, 2023, 23 (01)
  • [50] Prevalence of ESR1 Mutation in Chinese ER-Positive Breast Cancer
    Zhu, Wenzhen
    Ren, Chongyang
    Wang, Yulei
    Wen, Lingzhu
    Zhang, Guochun
    Liao, Ning
    ONCOTARGETS AND THERAPY, 2020, 13 : 615 - 621